Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Letizia Trincavelli

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|February 14, 2008
Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonistsBarbara Cosimelli, Giovanni Greco, Marina Ehlardo, et al.
Plos One|April 23, 2020
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosisChiara Parravicini, Davide Lecca, Davide Marangon, et al.
International Journal of Molecular Sciences|January 8, 2023
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New EvidenceSimona Daniele, Simona Saporiti, Stefano Capaldi, et al.
Cellular Signalling|January 11, 2012
A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromerMaria Letizia Trincavelli, Simona Daniele, Elisabetta Orlandini, et al.
Chemmedchem|March 14, 2008
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor modelTiziano Tuccinardi, Silvia Schenone, Francesco Bondavalli, et al.
Frontiers in Molecular Neuroscience|March 10, 2018
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease SeveritySimona Daniele, Daniela Frosini, Deborah Pietrobono, et al.
Nuclear Medicine and Biology|May 7, 2016
Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracerDebora Petroni, Chiara Giacomelli, Sabrina Taliani, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
ACS Chemical Neuroscience|April 4, 2017
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem CellsSimona Daniele, Deborah Pietrobono, Barbara Costa, et al.
Molecular Neurobiology|April 20, 2017
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy SubjectsSimona Daniele, Deborah Pietrobono, Jonathan Fusi, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|February 14, 2008
Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonistsBarbara Cosimelli, Giovanni Greco, Marina Ehlardo, et al.
Plos One|April 23, 2020
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosisChiara Parravicini, Davide Lecca, Davide Marangon, et al.
International Journal of Molecular Sciences|January 8, 2023
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New EvidenceSimona Daniele, Simona Saporiti, Stefano Capaldi, et al.
Cellular Signalling|January 11, 2012
A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromerMaria Letizia Trincavelli, Simona Daniele, Elisabetta Orlandini, et al.
Chemmedchem|March 14, 2008
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor modelTiziano Tuccinardi, Silvia Schenone, Francesco Bondavalli, et al.
Frontiers in Molecular Neuroscience|March 10, 2018
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease SeveritySimona Daniele, Daniela Frosini, Deborah Pietrobono, et al.
Nuclear Medicine and Biology|May 7, 2016
Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracerDebora Petroni, Chiara Giacomelli, Sabrina Taliani, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
ACS Chemical Neuroscience|April 4, 2017
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem CellsSimona Daniele, Deborah Pietrobono, Barbara Costa, et al.
Molecular Neurobiology|April 20, 2017
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy SubjectsSimona Daniele, Deborah Pietrobono, Jonathan Fusi, et al.
Pageof 9